• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Validation of the Japanese version of EORTC QLQ-CR38.

作者信息

Tsunoda A, Yasuda N, Nakao K, Yokoyama N, Marumori T, Hashimoto H, Kusano M, West K

机构信息

Department of General and Gastroenterological Surgery, Showa University School of Medicine, Tokyo, Japan.

出版信息

Qual Life Res. 2008 Mar;17(2):317-22. doi: 10.1007/s11136-007-9298-x. Epub 2007 Dec 20.

DOI:10.1007/s11136-007-9298-x
PMID:18095186
Abstract

PURPOSE

The objective of this study was to test the reliability and validity of the Japanese version of the European Organization for Research and Treatment of Cancer (EORTC) Colorectal Cancer-Specific Quality of Life Questionnaire (QLQ-CR38).

METHODS

The questionnaire was tested among 109 colorectal cancer patients on several occasions. The timing was prior to treatment with radiotherapy or chemotherapy, during treatment and 3 months following the second assessment. For purpose of test-retest reliability, a subgroup of patients completed the QLQ-CR38 1 week following the third assessment.

RESULTS

Multitrait scaling analysis confirmed the hypothesised scale structure of both the function scales and the symptom scales except female sexual problem scale. Cronbach's alpha coefficients for seven of the nine scales exceeded the 0.7 criterion at one or both assessments. The test-retest reliability for all scales except three symptom scales was 0.67 or higher. On the basis of known-groups comparisons, four of 46 comparisons distinguished between patients differing in disease stage, initial and on-treatment performance status and presence or absence of a stoma. Additionally, these scales detected change over time as a function of change in performance status and treatment-induced change.

CONCLUSION

These preliminary results suggest that the Japanese EORTC QLQ-CR38 may be a reliable and valid supplementary measure of quality of life in colorectal cancer patients.

摘要

相似文献

1
Validation of the Japanese version of EORTC QLQ-CR38.
Qual Life Res. 2008 Mar;17(2):317-22. doi: 10.1007/s11136-007-9298-x. Epub 2007 Dec 20.
2
The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.欧洲癌症研究与治疗组织结直肠癌特异性生活质量问卷模块(QLQ-CR38)的构建与测试。欧洲癌症研究与治疗组织生活质量研究小组
Eur J Cancer. 1999 Feb;35(2):238-47. doi: 10.1016/s0959-8049(98)00357-8.
3
Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQ-C30 in Colorectal Cancer Patients.欧洲癌症研究与治疗组织核心生活质量问卷C30中文版在马来西亚结直肠癌患者中的心理测量学验证
Asian Pac J Cancer Prev. 2015;16(18):8107-12. doi: 10.7314/apjcp.2015.16.18.8107.
4
Psychometric Validation of the Bahasa Malaysia Version of the EORTC QLQ-CR29.欧洲癌症研究与治疗组织QLQ-CR29马来西亚语版本的心理测量学验证
Asian Pac J Cancer Prev. 2015;16(18):8101-5. doi: 10.7314/apjcp.2015.16.18.8101.
5
Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer.验证丹麦版 EORTC QLQ-CR38 疾病特异性量表用于评估结直肠癌患者的健康相关生活质量。
Health Qual Life Outcomes. 2012 Dec 14;10:150. doi: 10.1186/1477-7525-10-150.
6
Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review.用于结直肠癌患者的FACT-C、欧洲癌症研究与治疗组织核心生活质量问卷CR38和核心生活质量问卷CR29生活质量问卷比较:一项文献综述
Support Care Cancer. 2016 Aug;24(8):3661-8. doi: 10.1007/s00520-016-3270-7. Epub 2016 May 18.
7
Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.《欧洲癌症研究与治疗组织核心生活质量问卷结直肠癌29项量表(EORTC QLQ-CR29)韩国版在结直肠癌患者中的文化调适与效度验证》
Support Care Cancer. 2015 Dec;23(12):3493-501. doi: 10.1007/s00520-015-2710-0. Epub 2015 Apr 1.
8
Development and validation of a simplified chinese version of EORTC QLQ-CR38 to measure the quality of life of patients with colorectal cancer.EORTC QLQ-CR38 简体中文版的制定与验证:用于评估结直肠癌患者的生活质量。
Oncology. 2012;83(4):201-9. doi: 10.1159/000341345. Epub 2012 Aug 11.
9
Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.《EORTC QLQ-C30 量表在摩洛哥结直肠癌患者中的信度和效度验证:横断面研究和系统文献回顾》。
BMC Cancer. 2021 Jan 27;21(1):99. doi: 10.1186/s12885-021-07793-w.
10
Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer.欧洲癌症研究与治疗组织核心生活质量问卷CR29中文版在结直肠癌患者中的效度验证
World J Gastroenterol. 2017 Mar 14;23(10):1891-1898. doi: 10.3748/wjg.v23.i10.1891.

引用本文的文献

1
Japanese Practice Guidelines for Fecal Incontinence Part 1-Definition, Epidemiology, Etiology, Pathophysiology and Causes, Risk Factors, Clinical Evaluations, and Symptomatic Scores and QoL Questionnaire for Clinical Evaluations-English Version.日本大便失禁实践指南 第1部分 - 定义、流行病学、病因、病理生理学与病因、危险因素、临床评估以及用于临床评估的症状评分和生活质量问卷 - 英文版
J Anus Rectum Colon. 2021 Jan 28;5(1):52-66. doi: 10.23922/jarc.2020-057. eCollection 2021.
2
Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.《欧洲癌症研究与治疗组织核心生活质量问卷结直肠癌29项量表(EORTC QLQ-CR29)韩国版在结直肠癌患者中的文化调适与效度验证》
Support Care Cancer. 2015 Dec;23(12):3493-501. doi: 10.1007/s00520-015-2710-0. Epub 2015 Apr 1.
3

本文引用的文献

1
Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer.S-1联合伊立替康(CPT-11)治疗晚期结直肠癌的I期研究。
Oncology. 2007;72(1-2):58-63. doi: 10.1159/000111095. Epub 2007 Nov 13.
2
Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer.对接受腹会阴联合切除术或直肠癌保肛手术患者生活质量的前瞻性评估。
Ann Surg Oncol. 2005 Feb;12(2):117-23. doi: 10.1245/ASO.2005.12.036. Epub 2005 Feb 4.
3
Hypogastric nerve preservation does not increase local recurrence after surgical treatment of rectal carcinoma.
Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer.验证丹麦版 EORTC QLQ-CR38 疾病特异性量表用于评估结直肠癌患者的健康相关生活质量。
Health Qual Life Outcomes. 2012 Dec 14;10:150. doi: 10.1186/1477-7525-10-150.
4
Translation and validation of the Japanese version of the fecal incontinence quality of life scale.粪便失禁生活质量量表的日译本翻译及验证。
Surg Today. 2013 Oct;43(10):1103-8. doi: 10.1007/s00595-012-0412-5. Epub 2012 Nov 11.
5
Health-related quality of life in patients with advanced colorectal cancer: results from a phase II study of S-1 combined with irinotecan (CPT-11).晚期结直肠癌患者的健康相关生活质量:S-1 联合伊立替康(CPT-11)的 II 期研究结果。
Int J Clin Oncol. 2010 Jun;15(3):280-6. doi: 10.1007/s10147-010-0059-4. Epub 2010 Mar 16.
6
Health-related quality of life of colorectal cancer patients receiving oral UFT plus leucovorin compared with those with surgery alone.结直肠癌患者接受 UFT 联合亚叶酸治疗与单纯手术治疗的健康相关生活质量比较。
Int J Clin Oncol. 2010 Apr;15(2):153-60. doi: 10.1007/s10147-010-0035-z. Epub 2010 Feb 27.
7
Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C.欧洲癌症研究与治疗组织结直肠癌特异性生活质量问卷(EORTC QLQ-CR38)和癌症治疗功能评估结直肠癌问卷(FACT-C)法语版本的验证
Qual Life Res. 2008 Apr;17(3):437-45. doi: 10.1007/s11136-008-9322-9. Epub 2008 Mar 13.
保留腹下神经不会增加直肠癌手术治疗后的局部复发率。
Hepatogastroenterology. 2004 Sep-Oct;51(59):1354-7.
4
Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer.腹会阴联合切除术或直肠癌前切除术患者生活质量的比较。
Ann Surg. 2001 Feb;233(2):149-56. doi: 10.1097/00000658-200102000-00001.
5
The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.欧洲癌症研究与治疗组织结直肠癌特异性生活质量问卷模块(QLQ-CR38)的构建与测试。欧洲癌症研究与治疗组织生活质量研究小组
Eur J Cancer. 1999 Feb;35(2):238-47. doi: 10.1016/s0959-8049(98)00357-8.
6
A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer.欧洲癌症研究与治疗组织QLQ-C30(EORTC QLQ-C30)在日本肺癌患者中的交叉验证。
Eur J Cancer. 1998 May;34(6):810-5. doi: 10.1016/s0959-8049(97)00395-x.
7
Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.欧洲癌症研究与治疗组织QLQ-C30问卷评估:与意大利长期存活癌症患者队列中的SF-36健康调查的比较
Ann Oncol. 1998 May;9(5):549-57. doi: 10.1023/a:1008264412398.
8
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators.一种新型口服5-氟尿嘧啶衍生物(S-1)的研发,该衍生物通过两种生化调节剂增强5-氟尿嘧啶的肿瘤选择性细胞毒性。
Anticancer Drugs. 1996 Jul;7(5):548-57. doi: 10.1097/00001813-199607000-00010.
9
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.欧洲癌症研究与治疗组织QLQ-C30:一种用于肿瘤学国际临床试验的生活质量评估工具。
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. doi: 10.1093/jnci/85.5.365.
10
The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life.欧洲癌症研究与治疗组织。生活质量评估方法:制定问卷模块指南。欧洲癌症研究与治疗组织生活质量研究小组。
Qual Life Res. 1993 Aug;2(4):287-95. doi: 10.1007/BF00434800.